Anika Therapeutics Inc. (ANIK) News
Filter ANIK News Items
ANIK News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ANIK News Highlights
- ANIK's 30 day story count now stands at 2.
- Over the past 16 days, the trend for ANIK's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- AVTX, CARG and HA are the most mentioned tickers in articles about ANIK.
Latest ANIK News From Around the Web
Below are the latest news stories about ANIKA THERAPEUTICS INC that investors may wish to consider to help them evaluate ANIK as an investment opportunity.
New Strong Buy Stocks for December 14thMUSA, AVTX, ANIK, CARG and WES have been added to the Zacks Rank #1 (Strong Buy) List on December 14, 2023. |
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market ReleaseIntegrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic acid (HA) regenerative portfolio BEDFORD, Mass., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that the first surgeries using the Integrity Implant System were successfully performed by Dr. Christopher Baker at the Florida O |
Anika to Participate in Upcoming Investor ConferencesBEDFORD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following investor conferences: The Stephens Annual Investment Conference at the Grand Hyatt, Nashville, TN, on Wednesday, November 15, 2023. T |
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call TranscriptAnika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good evening, ladies and gentlemen, and welcome to Anika’s Third Quarter 2023 Earnings Conference Call. All participants’ will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note today’s event […] |
Q3 2023 Anika Therapeutics Inc Earnings CallQ3 2023 Anika Therapeutics Inc Earnings Call |
Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year GuidanceJoint Preservation and Restoration revenue up 14%, OA Pain Management revenue up 2% in Q3 2023 |
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the BusinessRevenue Growth Exceeded Expectations in the Third Quarter and Year-To-Date, with Joint Preservation and Restoration up 14% and 10% and OA Pain Management up 2% and 11%, Respectively RevoMotion™ Reverse Shoulder Arthroplasty System Fully Launched at OSET Annual Meeting with Positive Surgeon Feedback Integrity™ Implant System, a Regenerative Hyaluronic Acid (HA)-Based Patch System for Augmentation of Rotator Cuff Repairs, and X-Twist™ Biocomposite Fixation System Both Cleared by the FDA; On-Track |
Anika Therapeutics, Inc. (NASDAQ:ANIK) is favoured by institutional owners who hold 66% of the companyKey Insights Institutions' substantial holdings in Anika Therapeutics implies that they have significant influence over... |
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023BEDFORD, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its third quarter 2023 financial results after the close of the market on Thursday, November 2, 2023 and hold its investor conference call on the same day, at 5:30 p.m. ET to discuss its financial results and business highlights. The conference call can be accessed by dialing 1-844-826-303 |
Investors in Anika Therapeutics (NASDAQ:ANIK) have unfortunately lost 52% over the last five yearsWe think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly... |